期刊文献+

膜反应性溶解抑制物在细胞及小鼠体内的表达

Expression of human CD59 protein in transgenic pig aortic endothelial cells and mice
原文传递
导出
摘要 目的观察外源基因在猪血管内皮细胞及小鼠体内表达情况。方法体外培养猪血管内皮细胞,脂质体转染法将pcDNA3-ICAM-2- EnhancerCD59cDNA转染猪的血管内皮细胞,以未转染的猪血管内皮细胞为阴性对照,人血细胞为阳性对照,经G418筛选(浓度为100mg/L)获得具有抗性的克隆,通过流式细胞仪检测转染细胞的表达情况。通过显微注射将CD59基因片段导入小鼠授精卵,对出生的小鼠进行基因检测。结果pcDNA3-ICAM-2-Enhancer-CD59cDNA重组质粒在细胞中表达强度为63.1%;转CD59基因小鼠外周血单核细胞(PBMCs)表达强度为73.38%。结论以人细胞间黏附因子Ⅱ(ICAM-2)为启动子并带增强子的CD59重组基因在猪的血管内皮细胞及小鼠体内均高效特异表达。 Objective To investigate the expression of human CD59 protein in transgenic pig aortic endothelial cells (PAECs) and mice. Methods The PAECs were cultured in vitro. The pcDNA3- ICAM-2-Enhancer-CD59cDNA was transfected into the PAECs by lipofectinnmine mediated method. Normal PAECs served as negative control and human PBMCs as positive control. Stable transfectants were selected using G418 (concentration 100 mg/L). The CD59 protein expression in transfected cells was assayed by flow cytometry. CD59 gene fragments were transferred into mouse zygote by micro-injection and new born pups were detected for transgene and genotyped. Results The expression intensity of pcDNA3- ICAM-2-Enhancer- CD59cDNA recombinant plasmid in PAECs was 63.1%. The expression intensity on the membrane of monocytes in periphery blood of transgenic mice of CD59 gene was 73.38%. Conclusion Recombinant CD 59 protein using ICAM-2 promoter with enhancer can be expressed highly, effectively and specifically in PAECs and transgenic mice.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2008年第10期1334-1335,共2页 Chinese Journal of Experimental Surgery
基金 天津市科技发展计划资助项目(043803411)
关键词 内皮细胞 转基因 基因表达 启动子 Endothelial cell Transgene Gene expre'ssion Promoter
  • 相关文献

参考文献7

  • 1Brovimans RA, Wierngen OAM, Van Es LA, et al, Relatiiv roles of decay-accelerating factor, membrane cofactor, and CD59 in the protecttion of human endothelial cells against complement lysis. Eur J Immunol, 1992,22:3135-3140.
  • 2Tom EM,Amt EF. Xenotransplantion: how to overcome the complent obstacle.9 Mol lmmuuol, 1999,36:269-276.
  • 3李胜芝,姚旭东,王广有,马腾骧,张泽,张玥.人CD59重组基因在猪血管内皮细胞中的表达[J].中华实验外科杂志,2004,21(10):1192-1193. 被引量:3
  • 4Johnston PS,Wang MW,Lim SM ,et al. Disseorrrdant xenografft rejection in an antibody-free model. Transplantation, 1992,54:573-576.
  • 5Tone M, Diamond LE, Walsh LA. High level transcription of the complement regulatory protein CD59 requires an enhancer located in intron I. J Biol Chem,1999,274:710-716.
  • 6He Z,She R,Sumitran-Holgersson S,et al. The in vitro activity and apecificity of human endothelial cell-specific promoter in procine cells. Xenotransplantation, 2001,8 : 202 -212.
  • 7Gordon JW, Scangos GA, Plotkin D J, et al. Genetic transferation of mouse embryos by microinjection of purified DNA. Proc Amd Natl Sci USA, 1980,77 : 1250-1254.

二级参考文献5

  • 1Damalsso AP ,Vercelotti GM,Platt JL,et al.Inhibition of complementmediated endothelial cell cytotoxicity by decayaccelerating factor.Transplantation,1991,52:530-533.
  • 2Tom EM,Arnt EF.Xenotransplantation:How to overcome the complement obstacle? Mol Immunol ,1999,36:269-276.
  • 3Johnston PS,Wang MW,Lim SM,et al.Disscorrrdant xenografft rejection in an antibody-free model.Transplantation,1992,54:573-576.
  • 4He Z,She R ,Sumitran-Holgersson S,et al .The in vitro activity and apecificity of human endothelial cell-specific promoter in procine cells .Xenotransplantation,2001,8:202-212.
  • 5Brovimans RA,Wieringen PAM,Van Es LA,et al,Relative role of decay-acclerating factor,membrane cofactor,and CD59 in the protection of human endothelial cells against complement mediated lysis.Eur J Immunol,1992,22:3135-3140.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部